Combination of PI3K/mTOR inhibitors: antitumor activity and molecular correlates.

Mazzoletti, Marco

Combination of PI3K/mTOR inhibitors: antitumor activity and molecular correlates. [electronic resource] - Cancer research Jul 2011 - 4573-84 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1538-7445

10.1158/0008-5472.CAN-10-4322 doi


Animals
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Cell Line, Tumor
Drug Administration Schedule
Drug Synergism
Female
Furans--administration & dosage
Humans
Male
Mechanistic Target of Rapamycin Complex 1
Mice
Mice, Nude
Multiprotein Complexes
Phosphoinositide-3 Kinase Inhibitors
Protein Kinase Inhibitors--pharmacology
Proteins--antagonists & inhibitors
Proto-Oncogene Proteins c-akt--metabolism
Pyridines--administration & dosage
Pyrimidines--administration & dosage
Sirolimus--administration & dosage
TOR Serine-Threonine Kinases--antagonists & inhibitors